Central Pharmaceuticals Ltd. (DSE: CENTRALPHL)
Bangladesh
· Delayed Price · Currency is BDT 14.50
-0.40 (-2.68%)
At close: Sep 12, 2024
Central Pharmaceuticals Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2014 |
| Net Income | -59.17 | -43.96 | -68.25 | -8.47 | -1,107 | 57.09 | Upgrade
|
| Depreciation & Amortization | 26.75 | 26.75 | 29.76 | 32.89 | 36.28 | 40.07 | Upgrade
|
| Other Amortization | 0.01 | 0.01 | 0.01 | - | - | - | Upgrade
|
| Other Operating Activities | 15.42 | 0.01 | 17.47 | 21.32 | 1,070 | -86.84 | Upgrade
|
| Change in Accounts Receivable | -1.3 | -1.3 | -0.05 | -23.03 | - | - | Upgrade
|
| Change in Inventory | 17.12 | 17.12 | 20.58 | -7.41 | - | - | Upgrade
|
| Change in Accounts Payable | 3.79 | 3.79 | 0.85 | -1.39 | - | - | Upgrade
|
| Change in Income Taxes | 0.18 | 0.18 | 0.16 | 0.89 | - | - | Upgrade
|
| Change in Other Net Operating Assets | 1.16 | 1.16 | 1.07 | -5.95 | - | - | Upgrade
|
| Operating Cash Flow | -0.13 | -0.33 | -1.12 | 1.8 | -0.41 | 10.33 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | - | -63.81% | Upgrade
|
| Capital Expenditures | - | - | - | -6.57 | - | -11.25 | Upgrade
|
| Investing Cash Flow | - | - | - | -6.57 | - | -11.25 | Upgrade
|
| Short-Term Debt Issued | - | - | 9.12 | - | 8.3 | 0.03 | Upgrade
|
| Long-Term Debt Issued | - | - | 7.92 | 25.21 | 12.49 | 0.03 | Upgrade
|
| Total Debt Issued | - | - | 17.04 | 25.21 | 20.78 | 0.05 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | 17.04 | 25.21 | 20.78 | 0.05 | Upgrade
|
| Common Dividends Paid | - | - | - | - | -11.98 | - | Upgrade
|
| Other Financing Activities | 0 | -0.01 | -17.47 | -21.45 | -9.98 | -0.07 | Upgrade
|
| Financing Cash Flow | 0 | -0.01 | -0.43 | 3.76 | -1.18 | -0.02 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | 0 | - | - | - | - | Upgrade
|
| Net Cash Flow | -0.12 | -0.34 | -1.55 | -1.02 | -1.59 | -0.95 | Upgrade
|
| Free Cash Flow | -0.13 | -0.33 | -1.12 | -4.78 | -0.41 | -0.93 | Upgrade
|
| Free Cash Flow Margin | -0.11% | -1.11% | -4.31% | -3.22% | -0.29% | -0.30% | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.04 | -0.00 | -0.01 | Upgrade
|
| Cash Interest Paid | - | - | 17.36 | 21.36 | 9.95 | - | Upgrade
|
| Cash Income Tax Paid | 0.35 | 0.35 | 0.11 | 5.95 | 9.08 | 18.1 | Upgrade
|
| Levered Free Cash Flow | - | 17.79 | 8.19 | -19.67 | 278.09 | 68.03 | Upgrade
|
| Unlevered Free Cash Flow | - | 17.79 | 19.04 | -6.32 | 284.31 | 90.3 | Upgrade
|
| Change in Net Working Capital | - | -20.95 | -22.61 | 36.89 | -935.45 | 0.23 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.